RWJ-157498

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameRWJ-157498
Drug Alias Namerhodanine beta-lactamase inhibitors (RW Johnson Res Inst)RWJ-157498RWJ-157479RWJ-313598
ClassificationSmall molecules
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRW Johnson Pharmaceutical Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRW Johnson Pharmaceutical Research Institute
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A